2013, Number 103
<< Back
Rev Enfer Infec Pediatr 2013; 26.27 (103)
Etmoidomaxilar aspergillosis in a patient with aplastic anemia. Case report and literature review
Prado-González TJ, Monroy-Colín VA, Tena-Iturralde MF, Hernández-Porras M
Language: Spanish
References: 8
Page: 274-278
PDF size: 232.44 Kb.
ABSTRACT
The main risk factors for aspergillosis are severe immunosuppression states such as severe and prolonged neutropenia. The penetration of
Aspergillus spp in the connective tissue and vascular thrombosis occurs and eventually tissue necrosis. A case of a preschool with aplastic anemia who developed aspergillosis etmoidomaxilar being managed with amphotericin B and voriconazole had a fatal outcome. Sinus aspergillosis is a rare entity. Fulminant invasive aspergillosis is a very serious process that usually affects immunocompromised patients. To avoid the high mortality and morbidity associated with this process, it is essential to diagnosis and early treatment.
REFERENCES
Girmennia C, Pizzarelli G, Pozzi E et al. Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole. Haematologica 2008;93(1):159-60.
Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B. Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 2010;143(5):614-20.
Katragkou A, Roilides E. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections. Curr Opin Infect Dis 2011;24(3):225-9.
Klepser M. The value of amphotericin B in the treatment of invasive fungal infections. J Crit Care 2011;26:225. e1–225.e10.
Kontoyiannis DP, Body GP. Invasive aspergilosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002;21:161-72.
Kaczmarek I, Bilska J, Osmola K, Nowaczyk MT. Radiologic picture of maxillary sinus aspergilloma. Otolaryngol Pol 2010;64(7):36-9.
Naeem F, Rubnitz JE, Hakim H. Isolated nasal septum necrosis caused by Aspergillus flavus in a immunocompromised child. Pediatr Infect Dis J 2011; 30(7):627-9.
Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergilosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60.
Full text